New York subway users more concerned about safety than Covid

Passengers on the New York subway seem to be more concerned about safety than the possibility of catching Covid-19, according to a survey conducted by the Metropolitan Transportation Authority (MTA).

Specifically, 72% of users claim to feel very concerned about “crime and harassment”, while 64% claim to be concerned about their health security, 69% about wearing a mask, 60% about social distance and 55% for the cleaning of the wagons.

“The data from our customer survey could not be clearer: Safety concerns are the most important for current passengers and for those looking to return to public transportation. An overwhelming majority of 76% of customers say that seeing uniformed in the system makes them feel safer, “said MTA spokesman Abbey Colling, in a statement sent to Efe.

The MTA has published this survey after the daily number of subway passengers surpassed two million users for the first time on April 8, a figure still well below the 5.5 million people who habitually used the subway before. of the pandemic, but well above that of a year ago, when the number of travelers plummeted by 90%, due to the expansion of Covid-19.

“We know that if our passengers feel safe from crime and safe from Covid, they will return to public transportation and return to the city, and we are dedicating all resources to continually address these issues, to continue to break the number of passengers per day milestones. after day as New York reopens, “Colling added.

In recent months, several attacks have been reported at stations and wagons in this mode of transport.

The survey shows that user satisfaction in relation to crime and harassment in the wagons fell by 16% to 26% and in the stations it fell by 8.2% to 34%.

As for former metro users, 36% say they have not returned to the subway due to their feeling of insecurity due to crimes and harassment.

Vaccination in New York is progressing at a good pace, with a quarter of its inhabitants vaccinated, while the authorities continue to favor the reopening of sectors and businesses that had been closed until now.

Wedding halls, concerts in closed places or leisure and entertainment centers may already open their doors in the city, although with limited capacity, which has also contributed to the reactivation of public transport.


United States suspends use of Johnson & Johnson vaccine – NBC Miami (51)

WASHINGTON DC – The federal authorities of the United States recommended this Tuesday to “pause” the administration of the coronavirus vaccine developed by the pharmaceutical company Johnson & Johnson to investigate reports of potentially dangerous blood clots, from which at least one woman has died until the moment.

The Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) said they were investigating thrombi detected in six women in the days after vaccination, combined with a reduced platelet count.

Federal authorities said in a subsequent press conference Tuesday that all of the affected women are between the ages of 18 and 48. A woman has died and a second Nebraska woman is hospitalized in serious condition.

“I know that people are worried. If they got the vaccine a month ago, they don’t have to worry. If they got the vaccine a few days ago, then they have to be aware of if they are experiencing any of the dangerous symptoms, “CDC deputy director Anne Schuchat said in a conference call.

The “dangerous” symptoms are different from the flu-like symptoms that can be experienced in the hours or days after receiving the vaccine, Schuchat explained.

Clot-related symptoms can manifest in the first three weeks and include: headaches, abdominal pain, leg pain, or breathing difficulties three weeks after the injection.

Experts say that all three are highly effective.

More than 6.8 million doses of the Johnson & Johnson vaccine, which is a single dose, have been administered in the US. Currently, this vaccine constitutes only a small percentage (less than 5%) of the vaccines administered in the country.

Jeff Zients, director of the team in charge of the federal government’s response to the pandemic, said the pause in the application of the Johnson & Johnson vaccine will not affect the national vaccination campaign.

“We have more than 25 million doses of Pfizer and Moderna vaccines available each week … that’s more than enough to continue at the current rate of about 3 million daily vaccinations,” Zients said in a statement.


Federal distribution channels, including mass vaccination centers, will temporarily stop using the drug, and states and other providers are expected to do the same.

Two other vaccines, Moderna’s and Pfizer’s, comprise the vast majority of inoculations administered in the US and are not affected by the hiatus.

CDC’s Advisory Committee on Immunization Practices will meet Wednesday to study the cases. The FDA has started its own investigation.

“Until the process is complete, we recommend a pause in the use of this vaccine as a precaution,” said Schuchat and Peter Marks, director of the FDA’s Center for Biological Evaluation and Research, in a joint statement.


Marks said there is currently no “definitive cause” for thrombi, but the cause would be related to “an immune response that occurs very rarely when people receive the vaccine.

Officials said treatment for these blood clots is different from other non-vaccine-related clots that can occur in the brain, and a specialist should be consulted immediately for treatment.

Both the FDA and CDC said the vaccine pause could be lifted “in a matter of days.”


The agencies recommend that those who have received the Johnson & Johnson vaccine and have experienced headaches, abdominal pain, leg pain, or breathing difficulties three weeks after the injection contact their doctor.

Authorities said they want to train vaccine manufacturers and healthcare professionals on the “singular treatment” for these blood clots.


Johnson & Johnson claimed it was aware of the clots, but insisted a link to its vaccine has not yet been unequivocally established.

“We are aware of thromboembolic events, including some with thrombocytopenia, have been reported in relation to vaccines against COVID-19,” the company said in a statement. “So far, a clear causal relationship between these unusual events and the vaccine has not been established,” he added.

Johnson & Johnson’s vaccine was cleared as an emergency remedy by the FDA in late February with grand ceremony, in the hope that by requiring a single dose and relatively easy storage conditions, it would boost the nationwide vaccination campaign. .


The safety and well-being of the people who use our products is our number one priority.

We are aware of an extremely rare disorder involving people with blood clots in combination with low platelets in a small number of people who have received our COVID-19 vaccine.

The Centers for Disease Control (CDC) and the US Food and Drug Administration (FDA) are reviewing data involving six reported cases in the US, of more than 6.8 million doses administered.

As a precaution, the CDC and FDA have recommended a pause in the use of our vaccine.

Internist Jaime Salas spoke about the blood clots in the brain that the Johnson & Johnson vaccine could cause in some people. To see more from Telemundo, visit

In addition, we have been reviewing these cases with the European health authorities. We have made the decision to proactively delay the launch of our vaccine in Europe and stop vaccines in all clinical trials of the Janssen COVID-19 vaccine while we update the guide for investigators and participants.

We have been working closely with medical experts and health authorities, and we strongly support the open communication of this information to healthcare professionals and the public.

The CDC and FDA have made available information on proper recognition and management due to the unique treatment required with this type of blood clot.

Health authorities advise that people who have received our COVID-19 vaccine and develop a severe headache, abdominal pain, leg pain, or shortness of breath within three weeks of vaccination should contact their care provider. medical.

For more information on the Janssen COVID-19 vaccine, click here.


Los Angeles stops use of Johnson and Johnson vaccine

Los Angeles stops use of Johnson and Johnson vaccine

The J&J vaccine is the only vaccine approved in the US that only requires one dose.

Matthew Hatcher / Getty Images

Los Angeles to temporarily stop administering Johnson & Johnson vaccine as recommended by federal health authorities on Tuesday morning after receiving reports of blood clots.

The pause in vaccination It will be in force at all vaccination points in the city until further notice. People who already have an appointment scheduled for Tuesday will receive another vaccine, as Deputy Mayor Jeff Gorell said on Twitter.

The California Department of Public Health has not yet ruled on whether the state will also stop running Johnson & Johnson for now.

Plans to expand eligibility and reopen the economy

Although health authorities already anticipated that there would be fewer doses of the Johnson & Johnson vaccine this week, a prolonged interruption of its use could significantly delay California’s vaccination campaign.

The Full state reopening, scheduled for June 15, is conditional on inoculation progress. But it is not yet clear whether Johnson & Johnson’s temporary suspension will affect Gov. Gavin Newsom’s goals.

Johnson & Johnson Vaccine Stoppage Announcement Arrives days before inoculation eligibility is extended to all state residents age 16 and older. However, many counties and cities have gotten ahead of state guidelines and are vaccinating the very young as well.

In the case of the city of Los Angeles, since last Sunday it allowed those over 16 years of age book an appointment at the vaccination points managed by the city. Since this Tuesday this age group has already begun to be vaccinated in the indicated places.

Vaccination Status in California

Up to now 23 million doses of the three COVID-19 vaccines have been administered in California approved in the United States. 38.8% of residents of the Golden State have received at least one dose, according to data from the Centers for Disease Control and Prevention (CDC).

Regarding the doses of Johnson & Johnson, nearly 850,000 have been injected, as shown by the same federal sources.

While last week they were assigned to the golden state 574,900 dosis de Johnson & Johnson, CDC data shows that this number was expected drop to 67,600 (88% less) and next week to 22,400 doses. Local and state authorities already counted on this collapse but, following the recommendation of federal agencies, even less will apply.

The supply of vaccines is expected Pfizer-BioNTech and Moderna not be an added problem this week and keep it relatively equal in California and across the country.


“Nobody wants to work anymore”: a McDonald’s restaurant apologizes in the US for lack of staff – Semana

  1. “Nobody wants to work anymore”: a McDonald’s restaurant apologizes in the US for lack of staffWeek
  2. VIDEO: McDonald’s apologizes for understaffing: ‘Nobody wants to work anymore’Entrepreneur
  3. McDonald’s apologizes for lack of staff: “No one wants to work anymore”
  4. A McDonald’s in the US apologizes to customers because “no one wants to work anymore”Tome pal pinto
  5. In this McDonald’s they apologize to their customers because nobody wants to workThe NY Journal
  6. See full coverage on Google News

Health authorities recommend pausing the use of the Johnson & Johnson vaccine

Por Alexander Smith – NBC News

Federal health agencies on Tuesday recommended stopping use of the Johnson & Johnson COVID-19 vaccine after a small number of people experienced “a rare and severe type of blood clot” after receiving the injection.

The Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) issued a statement recommending “a pause in the use of this vaccine as a precaution“.

About 6.8 million people have received the one-shot vaccine from this company in the United States. Six have experienced the clotAccording to the agencies: “At this time, these adverse events appear to be extremely rare,” they added.

[¿Qué debo hacer si recibí la vacuna de Johnson & Johnson? ¿Estoy en riesgo? ¿Y si tengo cita para vacunarme?]

Johnson & Johnson said in a statement that they were aware that blood clots had been reported with the administration of some COVID-19 vaccines, but that “a clear causal relationship has not been established between these rare events “and his vaccine.

“We continue to work closely with experts and regulators to evaluate the data and support the open communication of this information to healthcare professionals and the public,” he said.

According to the FDA and CDC, the six people who suffered clots were women between the ages of 18 and 48. They had what is called a cerebral venous sinus thrombosis, or CVST, as well as low levels of platelets in the blood.

“Treatment for this specific type of clot is different from what is usually given,” the statement said. Clots are usually treated with a blood thinner called heparin, but the use of this drug could be dangerous in the case of CVST, according to the statement.

[¿Podemos contagiarnos de COVID-19 al bañarnos en una piscina?]

CDC will convene a meeting of its Advisory Committee on Immunization Practices on Wednesday, which provides guidance on vaccines.

That committee was said to “further examine these cases and assess their possible significance,” while the FDA would also investigate. “Until that process is complete, we recommend this pause,” the joint statement says. The FDA is scheduled to hold a press conference Tuesday at 10 a.m. Eastern time.

The request for a pause reflects a situation that occurred in Europe last month.

Some European governments suspended the administration of the vaccine from the University of Oxford and AstraZeneca after an equally small number of people suffered blood clots from TSV. The AstraZeneca vaccine uses the same type of technology as the Johnson & Johnson injection.

[FEMA inicia el proceso de ayudas para gastos funerarios por muertes de COVID-19]

Since then, most European countries have resumed administration of the vaccine, but with a messy patchwork of different age restrictions and other guidelines. There are indications that as a result of this widely publicized fear, public confidence in this vaccine is lower than in others available.

[Hay un estado “en llamas” por una mutación del coronavirus. Y lo están sufriendo los más jóvenes]

The situation in Europe has divided experts, with some claiming governments cannot ignore the potential link, and others saying the hiatus may have increased infections and indecision, harms that far outweigh the dangers of these side effects. extremely rare.

AFM warns of a heated housing market and overstrained stock market

The records that are broken on the stock exchange are a cause for concern at the supervisory authority of the Netherlands Authority for the Financial Markets (AFM). “It feels uncomfortable and we are not completely reassured”, says chairman Laura van Geest. “Stock markets are breaking records and seemingly becoming detached from the real economy.”

2020 was a particularly turbulent year for the economy, the financial markets and the housing market, the AFM writes in its annual report. The corona pandemic collapsed the economy and the stock markets experienced turbulent times, with deep lows and new peaks and more investors. The housing market is overheated and prices are skyrocketing.

However, a lot went well and smoothly. The long-awaited Brexit and the shift of European securities trading to Amsterdam went smoothly, thanks in part to the good preparations of market parties. Things are less calm in other markets.

Younger investors

Calculated during the corona crisis, with all the uncertainty and volatility, interest in investing increased sharply, especially among young people. The number of investors rose by 11 percent to 1.6 million households.

More half of the starting investors are between 18 and 34 years old, more often with higher education than the experienced investor and more often women. They put in less money, but take more risks. 62 percent have less than 5000 euros to invest. Sustainable and green investing is increasingly important for many investors, but less of an issue for small investors.

The low interest rate on savings and the desire to build capital makes investing popular, stimulated by the emergence of convenient investment apps.

Starters not helped

The AFM continues to warn against the heated housing market where the old is rich and the young poor. “Start-ups go out of their way to get a home and because there is no additional housing supply, this only pushes up prices.

The tendency to give start-ups more funding with more flexible regulations seems sympathetic, but is counterproductive, according to the AFM. “More money leads to more demand and to higher prices. The problems for first-time buyers are only getting worse and make the current homeowner a happy buyer,” says Van Geest.

Building more would really help the housing market, but then the question is especially true. New construction sites often meet with protests from citizens, because they prefer not to have them in the greenery or in their own backyard. According to the AFM, housing construction mainly requires bravery from the government.

How can the stock market go so well in such difficult economic times? NOS op 3 explains that to you. In the stock market game below, you trade with insider information on the 2020 stock exchange. This is how you find out the winners and losers, and the cause of the rising prices.

Beverage market – Cola brings the Costa coffee chain to Switzerland and is planning up to 15 branches – Generation Z plays a central role

Beverage market

Cola is bringing the Costa coffee chain to Switzerland and is planning up to 15 branches – Generation Z plays a central role

The Swiss drink over 1,000 cups of coffee every year. The market dominated by Starbucks continues to grow strongly according to forecasts. The US beverage multinational Coca-Cola now also wants to benefit from this.

Costa Coffee is coming to Switzerland.

Costa Coffee is coming to Switzerland.

Photo: Costa Coffee

If Switzerland is addicted to one thing, it is coffee. The catering trade in this country generates around 2 billion francs annually with coffee; together with the retail trade and other channels, 3.1 billion francs are generated with the caffeine classics. The market is growing rapidly. Analysts expect additional sales of almost CHF 250 million between 2021 and 2025 alone.

The local Coca-Cola bottler Coca Cola HBC Switzerland now wants to cut a piece of the cake. In the course of this year he will bring the British coffee chain Costa Coffee to Switzerland, which the Coca-Cola Group acquired in 2019 for 5.1 billion dollars. The start in this country was actually planned for 2020. The corona crisis thwarted the company’s plans.

“We are not restaurateurs”

Own coffee houses are part of the strategy – but not only. The HBC manager Lorenz Haschemi, who is responsible for the expansion in Switzerland, speaks of “lighthouse objects”. By this he means his own coffee houses, but also shop-in-shop concepts. Haschemi says in an interview with CH Media during an exclusive visit to the Costa Coffee showroom in Brüttisellen ZH:

“We are planning 10 to 15 such properties in the next three to five years.”

These will be located in the big cities of Switzerland. Locations such as Zurich, Basel, Bern, Lucerne, St. Gallen or Geneva could be considered. Coca Cola HBC does not want to operate the branches itself, but is looking for franchisees. “We are not restaurateurs,” says Haschemi. Talks with possible partners were ongoing. Master franchising is also possible. In this model, a restaurant chain takes over the operation and development of a brand across the country.

Costa is already known as a brand

One advantage is that one in four Swiss people already knows the Costa Coffee brand, says Haschemi – from vacation trips, for example. Costa operates almost 4,000 coffee houses worldwide and is number two in the market after Starbucks. There is no getting around Starbucks in Switzerland either. The Seattle-based coffee company operates over 50 of its own coffee houses in this country. He also maintains a partnership with the kiosk and convenience shop operator Valora, which operates the important train stations and transport hubs. Starbucks beans, capsules and cold drinks are on the shelves at Coop and Migros.

Costa Coffee also wants to bring cold drinks to Swiss retailers.

Costa Coffee also wants to bring cold drinks to Swiss retailers.

Image: Coca-Cola HBC

Coca Cola HBC is pursuing a similarly comprehensive strategy. The bottler plans to install the Costa coffee machines developed by Thermoplan in Weggis LU in offices and semi-public spaces this year. The beans, capsules and drinks in aluminum cans should soon be available in Swiss retail outlets.

Know-How von Starbucks

Spicy: Lukas Henle, who only joined the company in February, is responsible for this. Before that, he was responsible for sales in the Swiss retail sector at Nestlé. And there it was, among other things, about launching the Starbucks coffee products in the supermarkets, since Nestlé took over the retail business of the US group for expensive money. Now Henle is trying to do the same with Costa Coffee. Coca-Cola also has a manager employed who was responsible for building Starbucks in this country at the time. This shows how serious the company is with the Swiss launch. Henle:

“We want to sell our products where they can be appropriately staged.”

The negotiations were ongoing. With whom, he doesn’t reveal. Coop, for example, can be considered as a partner. The retailer can already look back on a strong cooperation with Coca-Cola and is the first point of contact for branded products in the Swiss retail trade. Henle does not deny that. Coca Cola HBC is in talks with various retail partners, he says.

Coffee chains are entering the market

Costa Coffee will be positioned in the premium segment in Switzerland, he says. “In terms of age, Costa Coffee will appeal primarily to the younger Generation Z,” says Henle. This group, which consists mainly of today’s teenagers, values ​​values ​​such as regionality and high quality.

In addition to its own coffee houses, which are to be operated by franchisees, sales machines and the sale of products in the retail trade, Costa also wants to encourage Swiss hoteliers and restaurateurs to work together. For this, the coffee expert Martin Ponti trains gastro staff at the Coca-Cola location in Brüttisellen ZH. He previously worked for the Italian coffee producer Lavazza. The idea behind it:

Hotels and restaurants are to obtain machines, beans and the know-how from Costa Coffee and thus further anchor the brand in Switzerland.

The coffee market has recently grown strongly. This also shows the expansion of more and more independent, smaller chains. An example of this is the Zurich chain Vicafé, which has expanded from one location to 12 in Zurich and Basel over the past six years. The French-speaking coffee chain Boréal has ventured into German-speaking Switzerland, while Valora has greatly expanded its own coffee chain, Caffè Spettacolo. Nevertheless, the corona crisis is likely to make Costa Coffee’s entry into the market much more difficult. Coca-Cola manager Lukas Henle believes that the market will continue to grow after the corona crisis. “Switzerland remains profitable,” he says.

The Mitsubishi Eclipse Cross PHEV plug-in hybrid already has prices for Spain – News – Hybrids and Electric

Although a few weeks later what was initially announced, Mitsubishi has confirmed today the commercial premiere in Spain of its plug-in hybrid SUV, the Mitsubishi Eclipse Cross PHEV. It is currently the only electrified model that the Japanese firm has in its range in our country.

The plug-in hybrid Eclipse Cross thus begins its commercial journey in Spain with three different versions of equipment, Motion, Kaiteki and Kaiteki +, and whose price, they say, starts at 28,000 euros in our country. However, it is a rate that includes discounts and commercial campaigns. The official base price of the Motion variant is 41,500 euros, followed by 43,700 euros for the Kaiteki finish and 47,500 euros for the Kaiteki +.

Mitsubishi places special emphasis on its expertise in the field of plug-in hybrids, as they were among the first to enter this niche of electrified cars at the hands of the previous generation of the Outlander PHEV, of which they say there are more than 300,000 units circulating around the world. That is why its plug-in hybrid schemes seem to be the most reliable on sale today.


Mitsubishi Eclipse Cross PHEV.

The new Mitsubishi Eclipse Cross PHEV essentially draws on the same encufable hybrid scheme that was previously featured in the Outlander, but duly updated. The main protagonist continues to be the long-lived 2.4-liter atmospheric block, and is complemented by two electric motors that find space on each axle, so the Eclipse Cross PHEV has all-wheel drive.

While the gasoline engine produces a power of 72 kW (92 hp), the electric ones do the same with 60 kW (82 hp) on the front axle and 70 kW (95 hp) on the rear axle. The engine torque figures are 193, 137 and 195 Nm respectively. For its part, the battery in charge of supplying the energy to the electric motors is located under the floor of the passenger compartment, and has an energy capacity of 13.8 kWh. Thanks to this it is able to homologate according to the WLTP cycle, 55 kilometers of autonomy.

By default, the system chooses the most appropriate driving mode depending on aspects such as battery charge, acceleration and speed, although the driver can decide on what to prioritize, being able to choose between several modes, including electric driving (EV) a mode that prioritizes saving energy (SAVE) or recharging the battery at will (CHARGE).


Interior del Mitsubishi Eclipse Cross PHEV.

Mitsubhishi’s legacy in off-road driving and its experience in all-wheel drive systems is also reflected in the Eclipse Cross PHEV hand in hand with two traction management and control systems.

One of them calls it the Japanese firm Super All Wheel Control (S-AWC) that works in conjunction with the Twin Motor 4WD system, for which the electric motors distribute the torque independently and equitably between the front and rear axles. In conjunction with it, the system Active Yaw Control (AYC), controls the brakes and power steering to regulate the delivery of torque between the left and right wheels. Regardless of which mode the electrical system operates in, the system allows you to choose between Normal, Eco, Snow, Gravel or Tarmac riding modes.

The Mitsubishi Eclipse Cross PHEV can now be configured and reserved through its website, and it can also adhere to the Moves III state aid plan, although based on its approved autonomy, it will only be eligible for a 5,000 euro aid if gives a vehicle in exchange for more than 7 years for scrapping. In case of not delivering it, the aid will be 2,500 euros.


Unicredit, the Orcel era begins: sting on current accounts and closure of 450 branches

The cutting of 450 branches in Italy (here the list). Now Unicredit, very fresh from the exchange rate at the top, also raises the costs of current accounts: a +33% which certainly will not be easily digested by customers.

After the expulsion of Mustier, Andrea Orcel arrives at the helm of Unicredit and he already has the burning Montepaschi dossier on the table: it will be the first challenge for “the banker of steel”, writes the Financial Times in view of the shareholders’ meeting on April 15, called to approve the appointment of the new CEO.

How much will Orcel earn in Unicredit

From Unicredit Orcel will receive a fixed annual salary of 2.5 million euros, as well as a variable remuneration up to double the amount in shares of 5 million, for a total of 7.5 million.

Despite the record figures, and despite the goals as the first “Basket Bond of the supply chain” in collaboration with Cassa Depositi e Prestiti (200 million euros for business growth), it is a very delicate moment for Unicredit, which in the last 10 years lost something like 20 billion, while rival Intesa Sanpaolo, which has just acquired UBI Banca, earned 18.

About 287 thousand shareholders today, with 80.72% of the capital held by foreign parties, and only 19.28% by residents in Italy.

How many Unicredit branches close

Meanwhile, in Italy Unicredit continues its rationalization plan: closure of 450 branches, and investments in digital.

And just like Fineco, led by Alessandro Foti, Unicredit also saw fit to raise the costs of its current accounts, with a not indifferent sting for its account holders.

Fineco threatens to close the account of those who have more than 100 thousand euros without investing them, while UniCredit, Bnl and BPER, just to name a few, have opted for a maxi taxation of companies with large stocks, precisely to ensure that customers move money .

The letter sent by Unicredit to customers

Italian banks are trying in every way to cope with the consequences triggered by negative rates. Unicredit does so with a unilateral modification of the contract sent to subscribers of the MY GENIUS Account, reserved for individuals.

In its communication, Unicredit speaks of “economic balances” that would have failed, which can only be offset by increases in the monthly fees of savers’ accounts. “The market context in which the banking system operates has recently changed, impacting increasingly on banking activities and in particular on the deposit, management and remuneration of current account liquidity” writes Unicredit.

It is in this situation that, according to the letter to Unicredit customers, a worsening of the economic conditions for managing current account liquidity, mainly related to the persistent negative trend of the 3-month Euribor values, which has steadily reached negative values ​​below the Deposit facility rate (Dfr), ie the rate that the ECB applies to banks on the liquidity they hold with it.

Unicredit current accounts, all increases

And therefore, coming sting for Unicredit customers. In exchange, the bank changes the conditions of the borrowing rate of the existing credit lines or of the overdraft rate on the current account. But here’s how the monthly costs of current accounts change:

  • My Genius: da 1,78 a 3,03 euro (+70%)
  • Silver transactional: from 7.72 to 10.05 euros
  • Gold: da 10,83 a 14,42 euro
  • Platinum: from 19.97 to 23.56 euro
  • Platinum investment and Gold investment: no increase, they remain at 6.22 and 4.14 euros.


After the Greensill debacle: CS can further limit damage to customers

Credit Suisse is distributing an additional $ 1.7 billion to Greensill fund investors. The bank has now repaid CHF 4.8 billion to investors in the “supply chain financing” fund, which was valued at around CHF 10 billion at the end of February.

In the period between March 1 and April 9, CS received around $ 2 billion from the claims, the big bank announced on Tuesday. This results in a current cash position in the supply chain finance funds of $ 2.3 billion. Including the already distributed funds of 3.1 billion, this corresponds to more than half of the total assets under management of the four funds at the time all subscriptions and redemptions were suspended.

Published: April 13th, 2021, 11:41 am

Last updated: April 13th, 2021, 13:59